Literature DB >> 31984791

New roles of the Na+/H+ exchange regulatory factor 1 scaffolding protein: a review.

Adrienne M Bushau-Sprinkle1,2, Eleanor D Lederer3,2.   

Abstract

Na+/H+ exchange regulatory factor 1 (NHERF1), a member of a PDZ scaffolding protein family, was first identified as an organizer of membrane-bound protein complexes composed of hormone receptors, signal transduction pathways, and electrolyte and mineral transporters and channels. NHERF1 is involved in the regulation of Na+/H+ exchanger 3, Na+-dependent phosphate transporter 2a, and Na+-K+-ATPase through its ability to scaffold these transporters to the plasma membrane, allowing regulation of these protein complexes with their associated hormone receptors. Recently, NHERF1 has received increased interest in its involvement in a variety of functions, including cell structure and trafficking, tumorigenesis and tumor behavior, inflammatory responses, and tissue injury. In this review, we highlight the evidence for the expansive role of NHERF1 in cell biology and speculate on the implications for renal physiology and pathophysiology.

Entities:  

Keywords:  Na+/H+ exchange regulatory factor 1; cell biology; function; renal physiology and pathophysiology

Mesh:

Substances:

Year:  2020        PMID: 31984791      PMCID: PMC7395471          DOI: 10.1152/ajprenal.00467.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  59 in total

1.  Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.

Authors:  Jian-Qing Wang; Fu Qin; Liang Zhu
Journal:  J Int Med Res       Date:  2015-07-03       Impact factor: 1.671

2.  E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.

Authors:  Rosita Accardi; Rosa Rubino; Mariafrancesca Scalise; Tarik Gheit; Naveed Shahzad; Miranda Thomas; Lawrence Banks; Cesare Indiveri; Bakary S Sylla; Rosa A Cardone; Stephan J Reshkin; Massimo Tommasino
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

3.  The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.

Authors:  Anita Mangia; Lucia Caldarola; Stefania Dell'Endice; Emanuela Scarpi; Luca Saragoni; Manlio Monti; Daniele Santini; Oronzo Brunetti; Giovanni Simone; Nicola Silvestris
Journal:  Cancer Biol Ther       Date:  2015-06-30       Impact factor: 4.742

4.  Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia.

Authors:  L Fouassier; C Y Duan; A P Feranchak; C H Yun; E Sutherland; F Simon; J G Fitz; R B Doctor
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

5.  A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.

Authors:  Guifang DU; Chengcheng Hao; Yanan Gu; Zhiyan Wang; Wen G Jiang; Junqi He; Shan Cheng
Journal:  Anticancer Res       Date:  2016-03       Impact factor: 2.480

6.  NHERF1 mutations and responsiveness of renal parathyroid hormone.

Authors:  Zoubida Karim; Bénédicte Gérard; Naziha Bakouh; Rohia Alili; Christine Leroy; Laurent Beck; Caroline Silve; Gabrielle Planelles; Pablo Urena-Torres; Bernard Grandchamp; Gérard Friedlander; Dominique Prié
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

7.  Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) and nuclear factor-κB (NF-κB): a feed-forward loop for systemic and vascular inflammation.

Authors:  Kristen L Leslie; Gyun Jee Song; Stacey Barrick; Vanessa L Wehbi; Jean-Pierre Vilardaga; Philip M Bauer; Alessandro Bisello
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

8.  A molecular switch for the orientation of epithelial cell polarization.

Authors:  David M Bryant; Julie Roignot; Anirban Datta; Arend W Overeem; Minji Kim; Wei Yu; Xiao Peng; Dennis J Eastburn; Andrew J Ewald; Zena Werb; Keith E Mostov
Journal:  Dev Cell       Date:  2014-10-09       Impact factor: 12.270

9.  Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma.

Authors:  Tanner L Bartholow; Michael J Becich; Uma R Chandran; Anil V Parwani
Journal:  BMC Urol       Date:  2011-06-14       Impact factor: 2.264

10.  Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.

Authors:  Andrea Malfettone; Concetta Saponaro; Angelo Paradiso; Giovanni Simone; Annita Mangia
Journal:  BMC Cancer       Date:  2012-03-22       Impact factor: 4.430

View more
  4 in total

1.  Functional role and regulation of permeability-glycoprotein (P-gp) in the fetal membrane during drug transportation.

Authors:  Ananthkumar Kammala; Meagan Benson; Esha Ganguly; Lauren Richardson; Ramkumar Menon
Journal:  Am J Reprod Immunol       Date:  2021-12-15       Impact factor: 3.886

2.  Regulation of acid-sensing ion channels by protein binding partners.

Authors:  Megan M Cullinan; Robert C Klipp; John R Bankston
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

3.  NHERF1 Loss Upregulates Enzymes of the Pentose Phosphate Pathway in Kidney Cortex.

Authors:  Adrienne Bushau-Sprinkle; Michelle T Barati; Kenneth B Gagnon; Syed Jalal Khundmiri; Kathleen Kitterman; Bradford G Hill; Amanda Sherwood; Michael Merchant; Shesh N Rai; Sudhir Srivastava; Barbara Clark; Leah Siskind; Michael Brier; Jessica Hata; Eleanor Lederer
Journal:  Antioxidants (Basel)       Date:  2020-09-14

4.  Na/H Exchange Regulatory Factor 1 Deficient Mice Show Evidence of Oxidative Stress and Altered Cisplatin Pharmacokinetics.

Authors:  Adrienne M Bushau-Sprinkle; Michelle T Barati; Yuxuan Zheng; Walter H Watson; Kenneth B Gagnon; Syed Jalal Khundmiri; Kathleen T Kitterman; Barbara J Clark; Leah J Siskind; Mark A Doll; Michael E Brier; Susan Coventry; Eleanor D Lederer
Journal:  Antioxidants (Basel)       Date:  2021-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.